Bacteriostatic Water for Peptides

Bacteriostatic water for injection (BWFI) is sterile water preserved with 0.9% benzyl alcohol. The benzyl alcohol inhibits the growth of most common bacteria, which is what makes a multi-dose vial usable for repeated aseptic access. It is one of the most widely used diluents in peptide research because it balances peptide compatibility with practical vial life at the bench.

BWFI is distinct from sterile water for injection (no preservative, single-use once entered) and from 0.9% sodium chloride (isotonic saline, sometimes used when peptide chemistry allows).

• Extended working life. A reconstituted vial remains usable across multiple laboratory sessions rather than being discarded after a single entry.
• Broad peptide compatibility. Most linear and cyclized research peptides tolerate BWFI without measurable loss of activity during typical benchtop use.
• Reduced contamination risk. The bacteriostatic agent suppresses growth of common environmental contaminants that can otherwise degrade a shared research stock.

1. Bring the lyophilized vial to room temperature to reduce condensation on the vial walls.
2. Wipe both vial stoppers (peptide and BWFI) with a 70% isopropyl alcohol swab and allow to air-dry.
3. Draw the target volume of bacteriostatic water into a sterile syringe. Do not exceed the vial's practical fill volume.
4. Introduce the diluent slowly down the inside wall of the vial — never inject directly onto the lyophilized pellet, as shear force can denature sensitive peptides.
5. Gently swirl (do not shake or vortex) until the powder fully dissolves. Foaming is a sign of mechanical stress on the peptide.
6. Label the vial with the peptide identity, concentration, reconstitution date, and storage temperature.

The working concentration is calculated as concentration = peptide mass / diluent volume. A common convention is to express dose per 0.1 mL for straightforward laboratory aliquoting.

The table is illustrative only. Always verify labeled peptide mass against the certificate of analysis and adjust diluent volume to match the intended working concentration for your protocol.

• Lyophilized (unreconstituted): stable long-term at −20 °C or colder in the original sealed vial away from light and moisture.
• Reconstituted, refrigerated (2–8 °C): typically used within 2–4 weeks depending on peptide sequence and concentration.
• Reconstituted, frozen aliquots (−20 °C or colder): extended stability for many peptides. Avoid repeated freeze/thaw cycles — aliquot into single-use volumes.
• Bacteriostatic water itself: once entered, the manufacturer expiration for the preserved vial is generally 28 days at room temperature or per label.

• Use aseptic technique for every vial entry — new sterile needle and syringe each time.
• Store reconstituted vials upright and shielded from light where practical.
• Do not mix peptides from different lots or vials into a shared diluent.
• Discard vials that show cloudiness, particulate matter, discoloration, or a broken vacuum seal.
• Document reconstitution date, diluent lot, and final concentration in the laboratory notebook.

Some peptides — particularly highly hydrophobic sequences or those sensitive to benzyl alcohol — dissolve poorly in BWFI and require alternative diluents such as dilute acetic acid (0.1–1%), sterile water for injection, or DMSO for laboratory in-vitro work. Always confirm the recommended diluent from the peptide's certificate of analysis or technical data sheet before reconstitution.